Healthcare technology and consulting firm iMedicor, Nanuet, N.Y., has acquired iPenMD in an all-stock transaction with a private equity firm, saying the company's product will help physicians translate hand-written paper files automatically into electronic health records.
The seller, private equity firm JTJ Capital, received 9 million shares in the deal, which iMedicor CEO Fred Zolla said was equivalent to roughly $600,000. iMedicor is traded on the over-the-counter market under the ticker symbol VMCI.
Zolla said iPenMD's product is a “digital pen system” that reads a physician's handwriting and converts patient chart notes into editable text that flows into the correct fields in any EHR system that is certified for meaningful use.
Loading comments...
